Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab
Milena L Cavalcante,1 Victor M Villegas,2 Aaron S Gold,2 Ludimila L Cavalcante,1 Marcela Lonngi,1 Nisha V Shah,1 Timothy G Murray2 1Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA; 2Murray Ocular Oncology and Retina, Miami, FL, USA Objective: To report t...
Main Authors: | Cavalcante ML, Villegas VM, Gold AS, Cavalcante LL, Lonngi M, Shah NV, Murray TG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/treatment-of-vascular-activity-secondary-to-atypical-choroidal-nevus-u-peer-reviewed-article-OPTH |
Similar Items
-
Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation
by: Villegas VM, et al.
Published: (2014-05-01) -
Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
by: Palejwala NV, et al.
Published: (2014-09-01) -
Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
by: Houston SK, et al.
Published: (2013-01-01) -
Successful management of choroidal neovascular membrane secondary to choroidal osteoma with intravitreal bevacizumab
by: Brijesh Takkar, et al.
Published: (2017-04-01) -
Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
by: Farhad Fazel Najafabadi, et al.
Published: (2015-01-01)